Family Study of Lymphoproliferative Disorders

Genetic Epidemiology of Lymphoproliferative Disorders

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00626496

Enrollment

3000

Registered

2008-02-29

Start date

2004-04-01

Completion date

2029-12-31

Last updated

2025-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Monoclonal B-Cell Lymphocytosis, Multiple Myeloma

Brief summary

Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.

Interventions

None listed

Study design

Observational model

FAMILY_BASED

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.

Design outcomes

Primary

Measure	Time frame
Risk of blood or lymphoma	Ongoing

Countries

United States

Contacts

Primary ContactCatie Erding

Erding.Catherine@mayo.edu1-855-899-0693

Outcome results